Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Insider Sells $138,800.00 in Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) insider Helen Louise Collins sold 5,000 shares of the company’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $27.76, for a total transaction of $138,800.00. Following the transaction, the insider owned 25,000 shares of the company’s stock, valued at approximately $694,000. The trade was a 16.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Bitwise MARA Option Income Strategy ETF Stock Up 2.4%

Bitwise MARA Option Income Strategy ETF stock traded up $0.34 during mid-day trading on Thursday, reaching $14.46. The company had a trading volume of 1,889 shares, compared to its average volume of 5,966. The firm has a market cap of $3.47 million, a price-to-earnings ratio of 289.20 and a beta of -6.67. The company has a 50 day moving average of $14.89 and a 200-day moving average of $23.60. Bitwise MARA Option Income Strategy ETF has a 52 week low of $11.99 and a 52 week high of $60.73.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.